Louise Wang Zhiying Humphrey

Array ( [id] => 7176271 [patent_doc_number] => 20050123561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Radio lan access authentication system' [patent_app_type] => utility [patent_app_number] => 10/515253 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 3121 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123561.pdf [firstpage_image] =>[orig_patent_app_number] => 10515253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429229 [patent_doc_number] => 20040001805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA' [patent_app_type] => new [patent_app_number] => 10/298997 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12513 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001805.pdf [firstpage_image] =>[orig_patent_app_number] => 10298997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 748610 [patent_doc_number] => 07022325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'CD8 epitope from HIV-1 protein Vpu' [patent_app_type] => utility [patent_app_number] => 10/491008 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8098 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022325.pdf [firstpage_image] =>[orig_patent_app_number] => 10491008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196329 [patent_doc_number] => 07638269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Viral capsid assembly intermediates and methods of production' [patent_app_type] => utility [patent_app_number] => 10/243509 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 44 [patent_no_of_words] => 28075 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638269.pdf [firstpage_image] =>[orig_patent_app_number] => 10243509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765673 [patent_doc_number] => 20030100073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses' [patent_app_type] => new [patent_app_number] => 10/238114 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10124 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100073.pdf [firstpage_image] =>[orig_patent_app_number] => 10238114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990489 [patent_doc_number] => 20050089526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Human immunodeficiency virus envelope clycoprotein mutants and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/489040 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 62034 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089526.pdf [firstpage_image] =>[orig_patent_app_number] => 10489040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710028 [patent_doc_number] => 20060051373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/510268 [patent_app_country] => US [patent_app_date] => 2002-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 37823 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051373.pdf [firstpage_image] =>[orig_patent_app_number] => 10510268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778529 [patent_doc_number] => 20030049610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Detection of bovine viral diarrhea virus in hair samples' [patent_app_type] => new [patent_app_number] => 10/217253 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6564 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049610.pdf [firstpage_image] =>[orig_patent_app_number] => 10217253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851370 [patent_doc_number] => 20030143573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Detection of bovine viral diarrhea virus in tissue samples' [patent_app_type] => new [patent_app_number] => 10/217240 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6682 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143573.pdf [firstpage_image] =>[orig_patent_app_number] => 10217240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971275 [patent_doc_number] => 20050036985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases' [patent_app_type] => utility [patent_app_number] => 10/485180 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 21932 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20050036985.pdf [firstpage_image] =>[orig_patent_app_number] => 10485180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801252 [patent_doc_number] => 20030096417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Vaccination against feline immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/157319 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9655 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096417.pdf [firstpage_image] =>[orig_patent_app_number] => 10157319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348654 [patent_doc_number] => 07494767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Assay for TSG101 as inhibitors of HIV production' [patent_app_type] => utility [patent_app_number] => 10/478753 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 25 [patent_no_of_words] => 21074 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494767.pdf [firstpage_image] =>[orig_patent_app_number] => 10478753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8542887 [patent_doc_number] => 08318173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Chimeric vaccines' [patent_app_type] => utility [patent_app_number] => 10/474371 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29167 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10474371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683869 [patent_doc_number] => 20030119733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites' [patent_app_type] => new [patent_app_number] => 10/098238 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 20114 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119733.pdf [firstpage_image] =>[orig_patent_app_number] => 10098238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103434 [patent_doc_number] => 20050106160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens' [patent_app_type] => utility [patent_app_number] => 10/506651 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19291 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106160.pdf [firstpage_image] =>[orig_patent_app_number] => 10506651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787215 [patent_doc_number] => 20030138454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Vaccination method' [patent_app_type] => new [patent_app_number] => 10/079167 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 38754 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138454.pdf [firstpage_image] =>[orig_patent_app_number] => 10079167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6648931 [patent_doc_number] => 20030104577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'HIV capsid assembly-associated compositions and method' [patent_app_type] => new [patent_app_number] => 10/040206 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21272 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104577.pdf [firstpage_image] =>[orig_patent_app_number] => 10040206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43183 [patent_doc_number] => 07776523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Endogenous retroviruses up-regulated in prostate cancer' [patent_app_type] => utility [patent_app_number] => 10/016604 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 63 [patent_no_of_words] => 40391 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776523.pdf [firstpage_image] =>[orig_patent_app_number] => 10016604 [rel_patent_id] =>[rel_patent_doc_number] =>)